Atricure Inc (ATRC) - News Archive

Innovative Strides and Financial Ambitions: AtriCure’s Path to Preeminence in Cardiovascular Therapies In a series of groundbreaking announcements, AtriCure, Inc. (Nasdaq: ATRC) is demonstrating a robust commitment to a...

In a revealing announcement, AtriCure, Inc. (NASDAQ: ATRC), a pioneering entity in surgical treatments for atrial fibrillation (Afib) and related health issues, disclosed its preliminary financial results for the fourth...

In the ever-evolving landscape of medical technology, few companies are making as significant an impact as AtriCure, Inc. (Nasdaq: ATRC). Based in Mason, Ohio, this leading innovator specializes in surgical treatments a...

In the ever-evolving landscape of medical technology, innovation has become the heartbeat of progress. This rings particularly true in the field of surgical procedures and post-operative care, where patient comfort and...

AtriCure s Innovative Leap: Navigating Financial Challenges with European CE Certification MASON, Ohio In a remarkable stride forward, AtriCure, Inc. (Nasdaq: ATRC), a trailblazing innovator in the realm of surgical tre...

In an exciting development for the medical technology industry, AtriCure, Inc. (Nasdaq: ATRC), headquartered in Mason, Ohio, has received CE-Mark approval to market its EnCompass Clamp across countries in the European U...

AtriCure, Inc. a prominent player in medical innovation, has received an expanded indication for its AtriClip devices from the CE Mark authority in Europe. This advancement allows the use of AtriClip in treating patient...

AtriCure Expands AtriClip Indication: A Significant Advancement in Stroke Risk Reduction for Atrial Fibrillation PatientsIn a transformative stride for the treatment of atrial fibrillation (Afib) and related conditions,...

AtriCure: Innovation on Display at Prestigious Global Growth and Healthcare Crossroads Conferences In the rapidly advancing world of medical technology, AtriCure, Inc. (Nasdaq: ATRC) continues to steer the ship of innov...

AtriCure Revolutionizes Atrial Fibrillation Treatment with the Launch of AtriClip and cryoSPHERE+ ProbeMASON, Ohio - AtriCure, Inc. (Nasdaq: ATRC), a pioneering medical technology company specializing in surgical treatm...

AtriCure Set to Engage at the 2024 Leerink Partners Healthcare Crossroads ConferenceAtriCure, Inc. (Nasdaq: ATRC), a prominent player in the medical technology sector specializing in surgical treatments for atrial fibri...

In a definitive step forward in the medical technology industry, AtriCure, Inc., a leader in innovating surgical treatments and therapies for atrial fibrillation, left atrial appendage management, and post-operative pai...